Junior rheumatologist says EHRs equal the ‘End of Humane Reasoning’ when it comes to patient care, practice management
New Therapeutics for Osteoarthritis May Be in Sight
Overview of OA pathogenesis, recent discoveries suggest new treatment strategies are possible
Prior Authorization Requests Delay or Prevent Delivery of Needed Meds
Rheumatologist denounces common practice as a time-draining impediment to patient care
Atherosclerosis Insights May Shed Light on Lupus
New research compares pathogenic immune response in SLE with immune response that contributes to atherosclerotic plaque
The ACR Recommends Cautious Approach as Biosimilars Enter U.S. Market
With the U.S. FDA’s first approval of a biosimilar drug earlier this month, rheumatologists stress the need to ensure safety, efficacy of such drugs in treating rheumatic diseases
Infliximab, Tocilizumab Can Help in Large Vessel Vasculitis
Case studies show some patients with LVV can achieve remission after treatment with biological agents
Atherosclerosis, Cardiovascular Disease More Common in Patients with Primary Sjögren’s Syndrome
Study adds to research linking increased risk of morbidity, early mortality from CV events among patients with systemic autoimmune diseases
The Diagnostic View: Assess Your Rheumatology Knowledge
Radiograph, MR images of 54-year-old woman with right elbow pain
Coding Corner Question: March
Coding for chemotherapy infusion with a drug reaction
Certolizumab Pegol Drug Studies Find No New Safety Issues
Plus, updates on clazakizumab, hydrocodone bitartrate extended-release capsules and other rheumatology drug news, safety information
- « Previous Page
- 1
- …
- 584
- 585
- 586
- 587
- 588
- …
- 808
- Next Page »